Objective This study analyzed the impact of liver cirrhosis on cardiac structure, function, tissue characteristics, and stress perfusion using cardiac magnetic resonance (CMR) imaging. Materials and methods Fifty patients with liver cirrhosis and 25 matched, healthy controls received a 3-T CMR exam. Left and right ventricular (LV, RV) and atrial (LA, RA) volumes and functions were analyzed, including ejection fraction (EF), and feature tracking strain analysis. T1/T2 relaxation times and extracellular volume (ECV) were determined. Results Patients with cirrhosis showed a higher LVEF (66.6 ± 5.8 vs. 59.6 ± 4.5%, p < 0.001) and RVEF (65.4 ± 6.5 vs. 55.7 ± 8.0%, p < 0.001). LV (86.1 ± 16.2 vs. 78.0 ± 14 mL/m2, p = 0.038) volumes were higher in patients (48.8 ± 15.5 vs. 33.2 ± 9.1 mL/mL/m2, p = 0.014). RV volumes were also higher, but not statistically significant (85.1 ± 17.6 vs. 78.7 ± 13.8 mL/m2, p = 0.116). LV (−20.1 ± 3.4 vs. −17.1 ± 2.1%, p < 0.001) and RV global longitudinal strain (−25.8 ± 5.5 vs. −21.2 ± 5.4%, p = 0.001) were enhanced, similar to LV radial/circumferential strain. The Child-Pugh class and the model of end-stage liver disease (MELD) score were associated with an increase in ECV of 4.8 [1.8 to 7.8]% (p = 0.003) and 0.5 [0.2 to 0.8]% (p < 0.001). MELD was also associated with end-diastolic volumes (0.9 [0.1 to 1.7] mL/m2, p = 0.030 for the LV and 1.0 [0.1 to 1.9] mL/m2, p = 0.029 for the RV). No patient showed a perfusion deficit, while 20% showed non-ischemic late gadolinium enhancement (LGE). Conclusion Liver cirrhosis patients showed cardiac dilatation and increased ventricular function compared to controls. Non-ischemic LGE was present in 20% of patients. Disease severity scores were linked to an increased ECV and biventricular volumes. Key Points <Emphasis Type="BoldItalic">Question</Emphasis> The effect of liver cirrhosis on cardiac structure, function, perfusion, and tissue characteristics has not been sufficiently investigated using cardiac MR. <Emphasis Type="BoldItalic">Findings</Emphasis> Subjects with liver cirrhosis showed cardiac dilation, increased biventricular function compared to controls, non-ischemic LGE, and an association between disease severity and the extracellular volume. <Emphasis Type="BoldItalic">Clinical relevance</Emphasis> Liver cirrhosis results in cardiac changes characterized by MR, predominantly dilatation and hypercontractility, as well as signs of myocardial fibrosis and elevated extracellular volume with increasing disease severity. Graphical Abstract

Novel insights into cardiac structure, function, perfusion, and tissue characteristics in liver cirrhosis: a magnetic resonance analysis

期刊论文
出版模式：

开放获取
发表日期：

2025年6月5日

查看全文

Jennifer Erley,
Lieda Naimi,
Isabel Molwitz,
Destina G. Aydemir,
Ersin Cavus,
Kai Muellerleile,
Katharina A. Riedl,
Mathias Meyer,
Martina R. Sterneck,
Gunnar K. Lund,
Stefan Blankenberg,
Gerhard Adam,
Enver Tahir

摘要

Objective

This study analyzed the impact of liver cirrhosis on cardiac structure, function, tissue characteristics, and stress perfusion using cardiac magnetic resonance (CMR) imaging.

Materials and methods

Fifty patients with liver cirrhosis and 25 matched, healthy controls received a 3-T CMR exam. Left and right ventricular (LV, RV) and atrial (LA, RA) volumes and functions were analyzed, including ejection fraction (EF), and feature tracking strain analysis. T1/T2 relaxation times and extracellular volume (ECV) were determined.

Results

Patients with cirrhosis showed a higher LVEF (66.6 ± 5.8 vs. 59.6 ± 4.5%, p < 0.001) and RVEF (65.4 ± 6.5 vs. 55.7 ± 8.0%, p < 0.001). LV (86.1 ± 16.2 vs. 78.0 ± 14 mL/m², p = 0.038) volumes were higher in patients (48.8 ± 15.5 vs. 33.2 ± 9.1 mL/mL/m², p = 0.014). RV volumes were also higher, but not statistically significant (85.1 ± 17.6 vs. 78.7 ± 13.8 mL/m², p = 0.116). LV (−20.1 ± 3.4 vs. −17.1 ± 2.1%, p < 0.001) and RV global longitudinal strain (−25.8 ± 5.5 vs. −21.2 ± 5.4%, p = 0.001) were enhanced, similar to LV radial/circumferential strain. The Child-Pugh class and the model of end-stage liver disease (MELD) score were associated with an increase in ECV of 4.8 [1.8 to 7.8]% (p = 0.003) and 0.5 [0.2 to 0.8]% (p < 0.001). MELD was also associated with end-diastolic volumes (0.9 [0.1 to 1.7] mL/m², p = 0.030 for the LV and 1.0 [0.1 to 1.9] mL/m², p = 0.029 for the RV). No patient showed a perfusion deficit, while 20% showed non-ischemic late gadolinium enhancement (LGE).

Conclusion

Liver cirrhosis patients showed cardiac dilatation and increased ventricular function compared to controls. Non-ischemic LGE was present in 20% of patients. Disease severity scores were linked to an increased ECV and biventricular volumes.

Key Points

Question The effect of liver cirrhosis on cardiac structure, function, perfusion, and tissue characteristics has not been sufficiently investigated using cardiac MR.

Findings Subjects with liver cirrhosis showed cardiac dilation, increased biventricular function compared to controls, non-ischemic LGE, and an association between disease severity and the extracellular volume.

Clinical relevance Liver cirrhosis results in cardiac changes characterized by MR, predominantly dilatation and hypercontractility, as well as signs of myocardial fibrosis and elevated extracellular volume with increasing disease severity.

Graphical Abstract